8-K

Company

Akari Therapeutics Plc

Filed

August 18, 2015

Period of Report

August 17, 2015

Accession Number

0001144204-15-050306

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →